Skip to main content
. 2009 Dec 29;107(1):169–174. doi: 10.1073/pnas.0907739107

Fig. 3.

Fig. 3.

Mutations in the Polycomb silencing antagonist, trithorax, suppress the increased longevity of E(z) mutants. (A) E(z)60/+ mutants live 21% longer than C-S whereas E(z)60 trxB11/+ + double mutants live 5% longer than C-S. trxB11/+ mutants themselves show no difference in median life span compared to C-S (P < 0.001; C-S n = 298; E(z)60 n = 296; trxB11 n = 297; E(z)60 trxB11 n = 295). (B) E(z)60/+ mutants live 4.5% longer than E(z)60 trxZ11/+ double mutants. trxZ11/+ mutants show no difference in median life span compared to C-S (C-S n = 292; E(z)60 n = 296; trxZ11 n = 294; E(z)60 trxZ11 n = 293). Life span assays were conducted independently at 29 °C under constant humidity (approximately 50%). Reported P values are from Mantel-Cox log-rank statistical analysis.